KELA LINDSEY: Open Payments
NPI 1427274695 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 9 payments from 7 companies in 2025. Trend: 2023 $2,143 · 2024 $2,273 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $91 |
| ABIOMED | 1 | $59 |
| AtriCure, Inc. | 1 | $43 |
| Pulmonx Corporation | 1 | $39 |
| INOGEN, INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
Products named: DUPIXENT, SYNERGY ABLATION SYSTEM, CHARTIS CATHETER, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, VERQUVO, LifeVest.
Industry payments across OK — which companies pay providers there.
